Labcorp (LH)Officer sold ~$494K

~$494K

Approx. value · 2,000 sh @ $247.00

30K

Holds after · shares reported

Traded

Jun 3, 2025

Filed

Jun 5, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 31, 2025CongressDisclosed partial sale of LH — reported range $1,001 - $15,000
2. Apr 8, 2025CongressDisclosed sale of LH — reported range $1,001 - $15,000
3. May 1, 2025Insider · 2 peopleInsiders: 2 sales (~$654K)
4. May 12, 2025InsiderCEO sold ~$1.52M of LH shares in the open market
5. May 15, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
6. Jun 3, 2025 · this disclosureInsiderOfficer sold ~$494K of LH shares in the open market

What came next

1. Jun 11, 2025InsiderDirector sold ~$130K of LH shares in the open market
2. Jul 1, 2025InsiderDirector sold ~$133K of LH shares in the open market
3. Jul 24, 2025InsiderDirector sold ~$980K of LH shares in the open market
4. Jul 29, 2025Insider · 1 personInsiders: 2 sales (~$53K)
5. Jul 30, 2025InsiderDirector sold ~$530K of LH shares in the open market
6. Aug 11, 2025InsiderCEO sold ~$1.51M of LH shares in the open market
7. Aug 13, 2025InsiderOfficer sold ~$1.06M of LH shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Labcorp

For Labcorp, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports and 13 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LH page.

Other recent filings by Brian J Caveney, EVP, Pres of ED, CMO & CSO

• SEC Form 4 at Labcorp (LH)Feb 26, 2026

The full history of Brian J Caveney, EVP, Pres of ED, CMO & CSO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Labcorp

• House Clerk periodic transaction reportSep 9, 2026
• House Clerk periodic transaction reportSep 9, 2026
• House Clerk periodic transaction reportSep 9, 2026
• House Clerk periodic transaction reportSep 9, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its LH page.